JORGE DEL TORO: Open Payments
NPI 1730290107 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 110 payments from 20 companies in 2025. Trend: 2023 $1,971 · 2024 $1,962 · 2025 $2,023
Food & beverage: $1,914Education: $109
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $287 |
| PFIZER INC. | 13 | $287 |
| AstraZeneca Pharmaceuticals LP | 9 | $239 |
| GlaxoSmithKline, LLC. | 15 | $191 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $164 |
| ABBVIE INC. | 7 | $152 |
| Teva Pharmaceuticals USA, Inc. | 4 | $144 |
| Otsuka America Pharmaceutical, Inc. | 6 | $129 |
| Lilly USA, LLC | 4 | $67 |
| Amgen Inc. | 4 | $65 |
Products named: Wegovy, XIFAXAN, TRELEGY ELLIPTA, NURTEC ODT, REXULTI, UBRELVY, BREZTRI, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
